South Korea
Sonde is its second global digital health investment to date.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
Also, Max Life in India has developed an analytics solution that detects inaccurate medical reports in real time.
Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.
Individuals are also less likely to trust AI-suggested interventions than those recommended by humans.
The company will maintain its patent right for the technology.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
It will use its latest funds for its global expansion.
It measures the cortical thickness in a brain scan to provide a patient's level of brain ageing.
The clearance signals the company's move to offer medical AI devices to consumers.